Načítá se...
Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
PURPOSE: Oral capecitabine has been used as adjuvant therapy for colorectal cancer patients since the 1990s. Patient-initiated cessation or reduced use of capecitabine occurs widely for various reasons, yet the consequences of these actions are unclear. The present study sought to clarify treatment...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Society of Coloproctology
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2998011/ https://ncbi.nlm.nih.gov/pubmed/21152231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2010.26.4.287 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|